Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer
Status:
Terminated
Trial end date:
2021-03-03
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to look at the safety and side effects of combining the
drug pembrolizumab with imiquimod, GM-CSF, and cryotherapy to treat breast cancer that
includes skin lesions.